Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Metadata
Title
Current Role and Future Developments of Radiotherapy in Early-stage Favourable Hodgkin's Lymphoma
Authors
Hans Theodor Eich
Prof. Dr. Rolf-Peter Müller
Publication date
01-12-2007
Publisher
Urban & Vogel
Published in
Strahlentherapie und Onkologie / Issue Special Issue 2/2007
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-007-2007-4

Other articles of this Special Issue 2/2007

Strahlentherapie und Onkologie 2/2007 Go to the issue

Supplement Article

Prostate Cancer: Biological Dose Considerations and Constraints in Tele- and Brachytherapy

Supplement Article

IORT and External Beam Irradiation (EBI) in Clinical Stage I–II NSCLC Patients with Severely Compromised Pulmonary Function: An 52-Patient Single-institutional Experience

Supplement Article

IGRT with Helical Tomotherapy – Effort and Benefit in Clinical Routine

Supplement Article

Photons or Protons: Precision Radiotherapy of Lung Cancer

Supplement Article

IORT with Electrons as Boost Strategy during Breast Conserving Therapy in Limited Stage Breast Cancer: Results of an ISIORT Pooled Analysis

Supplement Article

Dose Escalated External Beam Radiotherapy versus Neoadjuvant Androgen Deprivation Therapy and Conventional Dose External Beam Radiotherapy for Clinically Localized Prostate Cancer: Do we Need Both?